Should Interventional Cardiologists Be Involved in Acute Stroke?

According to this single-site study, published in J Am Coll Cardiol Intv., interventional cardiologists can safely conduct revascularizations in a setting of acute stroke, with high clinical and technical success. Cardiologists are taking on this traditional interventional neurology field simply due to the lack of interventional neurologists, who are thus unable to provide coverage 24/7, 365 days per year.

Síndrome de Hiperperfusión cerebral post-angioplastia carotídea: una complicación prevenible

However, this brings about hidden costs. Even cardiologists with great experience and technical skills have limited knowledge of intracranial anatomy, CTs, MRIs, clinical aspects, and—particularly—how to manage catastrophic complications such as intracranial bleeding.

There should be no shortcuts in training. Thinking that a given vascular disease is similar to all others is a big mistake.

Taking into account that acute stroke interventions have not improved mortality, only disability (a much softer endpoint), and that a complication such as intracranial bleeding can reach a mortality rate of up to 70%, it is easy to imagine that a slight increase in the rate of complications can translate into a prognosis that is worse than natural disease progression.


Read also: SOLACI Symposium at SOCIME Congress 2019.


The study included 70 consecutive patients who, between 2012 and 2018, underwent acute stroke intervention for large-vessel occlusion. In 61% of cases, patients received fibrinolytic therapy after baseline imaging.

The mean time between symptom onset and arrival to the cath lab was 138 minutes, and the mean door-to-vascular access time was 64 minutes.

The best aspect of this work (one that a team of interventional neurologists would have a hard time reproducing) are the mere 13 minutes required between interventional team activation and its readiness. Undoubtedly, our experience and organization in relation to acute myocardial infarction has paid up.

In most patients, thrombectomy was done with a stent retriever. An aspiration system or a combination of techniques were also used.



Read also: Best Conduits and Best Surgeons for the Best Outcome.


Recanalization was technically successful (Thrombolysis In Cerebral Infarction flow grade 2b or 3) in 93% of patients.

The 30-day mortality was 18% and favorable clinical outcome (modified Rankin scale score of 0 to 2) was achieved in 61% at 3 months.

Conclusion

Acute stroke interventions can be conducted safely and with high technical and clinical success by experienced interventional cardiologists.

Original title: Acute Stroke Interventions Performed by Cardiologists Initial Experience in a Single Center.

Reference: Marius Hornung et al. J Am Coll Cardiol Intv 2019;12:1703–10.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

tromb

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...